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Abstract
Background: The development of postoperative granulation tissue is one of the main postoperative risks
after lumbar spine surgery. This granulation tissue may lead to persistent or new clinical symptoms or
complicate a follow up surgery. A sensitive non-invasive imaging technique, that could diagnose this
granulation tissue at the bedside, would help to develop appropriate treatments. Thus, the purpose of this
study was to establish a fast and economic imaging tool for the diagnosis of granulation tissue after lumbar
spine surgery, using a new integrated Optical Imaging (OI)/X-ray imaging system and the FDA-approved
fluorescent contrast agent Indocyanine Green (ICG).
Methods: 12 male Sprague Dawley rats underwent intervertebral disk surgery. Imaging of the operated
lumbar spine was done with the integrated OI/X-ray system at 7 and 14 days after surgery. 6 rats served
as non-operated controls. OI/X-ray scans of all rats were acquired before and after intravenous injection
of the FDA-approved fluorescent dye Indocyanine Green (ICG) at a dose of 1 mg/kg or 10 mg/kg. The
fluorescence signal of the paravertebral soft tissues was compared between different groups of rats using
Wilcoxon-tests. Lumbar spines and paravertebral soft tissues were further processed with histopathology.
Results: In both dose groups, ICG provided a significant enhancement of soft tissue in the area of surgery,
which corresponded with granulation tissue on histopathology. The peak and time interval of fluorescence
enhancement was significantly higher using 10 mg/kg dose of ICG compared to the 1 mg/kg ICG dose. The
levels of significance were p < 0.05. Fusion of OI data with X-rays allowed an accurate anatomical
localization of the enhancing granulation tissue.
Conclusion: ICG-enhanced OI is a suitable technique to diagnose granulation tissue after lumbar spine
surgery. This new imaging technique may be clinically applicable for postoperative treatment monitoring.
It could be also used to evaluate the effect of anti-inflammatory drugs and may even allow evaluations at
the bedside with new hand-held OI scanners.
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Background
It is estimated that annually 8% of the working popula-
tion in the US has lower-back related injuries [1]. A large
proportion of these disabilities are related to vertebral disc
herniations of the lumbar spine and can be treated by
removing the protruded disk elements [2].
One of the associated risks of lumbar spine surgery is the
development of postoperative granulation tissue. This
granulation tissue may lead to postoperative complica-
tions such as, recurrent radicular pain, muscle weakness
and paresthesia [3] and also contributes to further compli-
cations in the event of a follow up surgery [4-8].
Evaluation of disease progression and response to thera-
pies is essential for treatment optimization and monitor-
ing. Currently, the modalities used for imaging post-
operative granulation tissue in patients includes, mag-
netic resonance (MR) imaging, computed tomography
(CT) and SPECT/PET. However, each of these techniques
is associated with shortcomings. Radiotracers can target
granulation tissue with a high sensitivity [9,10], but
SPECT and PET provide limited anatomical resolution
and considerable radiation exposure. CT is readily accessi-
ble and offers excellent anatomical resolution, but is also
associated with high radiation exposure [11]. MR has
become the principal imaging technique for postoperative
evaluations of the lumbar spine since it provides three-
dimensional imaging data with excellent anatomical reso-
lution and a high soft tissue contrast. However, MR is an
expensive technique, which may be logistically compli-
cated in post-surgical patients because it is not available at
the bedside. In addition MR imaging may be confounded
by potential artifacts due to surgical implants [12-20].
Optical imaging (OI) is a relatively new, inexpensive, fast,
non-invasive and non-ionizing imaging technique based on
the detection of fluorescence [21,22]. In order to enhance
the contrast of OI, FDA-approved fluorescent dyes have
been developed. Because these dyes accumulate in highly
vascular areas visualization of granulation tissue with con-
trast enhanced OI can be done with high sensitivity.
A limited number of applications of OI for musculoskele-
tal disorders have been described so far, which is mainly
due to the fact that this technique only allows for depic-
tion of soft tissues and not the skeleton. To overcome
these drawbacks, new integrated OI-/X-ray imaging sys-
tems have been developed that acquire and fuse optical
images and X-rays. These fused OI-/X-ray images combine
the high sensitivity of OI [23,24], with the direct depiction
of the skeleton on X-rays. Our hypothesis was that these
new integrated OI/X-ray systems provide a time- and cost-
efficient approach for imaging granulation tissue after
spine surgery.
Thus, the purpose of this study was to investigate the per-
formance of an integrated OI-/X-ray imaging system for
the diagnosis and localization of granulation tissue fol-
lowing lumbar spine surgery in a rat model. We deter-
mined the best timing and dose of an FDA-approved
contrast agent that provided an optimal detection of post-
operative granulation tissue on OI/X-ray images and then
compared this data with histopathology. To the best of
our knowledge, this is the first investigation of the per-




This study was approved by the committee on animal
research at our institution. Eighteen male Sprague-Dawley
rats (Charles River Laboratories, Wilmington, MA) aged 3
months and weighing 280–300 g were randomly divided
into two groups of non-operated control animals (group
A) and animals that underwent spine surgery (group B).
Prior to the surgical procedure each rat from group B
received antibiotics (Trimethoprim-Sulfamethoxazole
(Hi-Tech Pharmacal, Amityville, NY), 5 mg/kg, per os)
and an intraperitoneal injection of buprenorphine
(Reckitt Benckiser Pharmaceuticals Inc., Richmond,
VA)(0.01–0.02 mg/kg). The animals were anesthetized
with a single intraperitoneal injection of 35 mg/kg
Sodium-Pentobarbital (Abbott Laboratories, Chicago, IL).
After a vertical posterolateral skin incision and dissection
through the left paravertebral muscles, the spine was
exposed and a 20 gauge needle was inserted through the
intervertebral disc at the level L2/3, keeping the annulus
inside the cannula of the needle. The needle was advanced
until it passed out of the posterior annulus as confirmed
by fluoroscopy and then removed with the annulus
inside.
At this point a second incision was made in the anterior
portion of the upper tail in order to expose three tail
intervertebral discs. A 16 gauge needle was passed through
one of these discs, thereby collecting a portion of the
nucleus pulposus. This material was reloaded into the
above mentioned annulus-loaded 20 gauge needle. The
loaded needle was then reinserted into the previously
approached lumbar level (L2/3) and the needle contents
(annulus and nucleus) were pushed with a stylus into the
intervertebral disc of L2/3, thereby creating a disc protru-
sion and local granulation tissue.
After completion of this procedure, the abdominal wall
and tail incisions were closed. Post-operative pain was
controlled by intraperitoneal injection of buprenorphine
every 8–12 hours for the first 48 hours. Medication withJournal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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Trimethoprim-Sulfamethoxazole was continued for 72
hours post surgery (p.s.).
Contrast medium
Indocyanine Green (ICG) is an FDA-approved approved,
hydrophilic anionic near-infrared (NIR) dye with a molec-
ular weight of 774.97 Da. The absorption and emission
maximum wavelength of ICG are 805 and 830 nm respec-
tively, which is within the NIR spectrum. ICG is rapidly
cleared by the liver and bile fluid with a blood half-life of
3–4 minutes [25]. ICG shows a reversible plasma protein
binding of up to 98% a few seconds after i.v. injection and
a very low toxicity.
For this study, 20 mg of ICG (Fisher Scientific, Waltham,
MA) was dissolved in 800 μl dimethyl sulfoxide (DMSO)
(Fisher Scientific, Waltham, MA). This stock solution was
diluted with saline to yield a 10 mg/ml or 1 mg/ml solu-
tion. In order to remove potential bacterial or dust con-
taminations, the solution was filtered through a 0.2 μm
nylon filter (Alltech, Breda, Netherlands) directly before
intravenous injection.
In vivo imaging
All 18 rats were investigated with optical imaging (OI)
and subsequent X-rays. The non-operated control group
of six animals was divided further into two groups that
received an intravenous injection of 1 mg/kg ICG (group
A1, n = 3) or 10 mg/kg ICG (group A2, n = 3, Figure 1).
Likewise, the animals of Group B, that had undergone
lumbar surgery, were also divided into two groups that
received either intravenous injections of 1 mg/kg (Group
B1, n = 6) and 10 mg/kg ICG (Group B2, n = 6, Figure 1).
The dose of 1 mg/kg was chosen as the typical dose cur-
rently applied for clinical applications [26,27] and the
dose of 10 mg/kg was chosen as a dose previously used in
rodents [28,29]. All animals in Group B underwent imag-
ing studies at 7 days (n = 12) and 14 days (n = 12) after
the spine surgery. Each imaging study of Group A and B
consisted of the following protocol: (1) a pre-contrast OI
scan, (2) ICG-injection, (3) OI scans from 1–25 min post
injection (p.i.) and (4) X-rays at 30 minutes p.i.
For all OI scans, the animals were anaesthetized with 1.5
– 2.0% Isoflurane (Narkomed, Telford, PA) in oxygen.
The rats were placed prone and lateral into the OI scanner
(Imaging Station FX, Eastman Kodak Company, New
Haven, CT). This OI system is equipped with a 150-W
high-intensity halogen illuminator. For detection of ICG
fluorescence, the excitation filter was set at 755 nm, the
emission filter was set at 830 nm. Emitted light was col-
lected using a thermoelectrically cooled CCD camera. The
following imaging parameters were used for OI imaging:
exposure time: 5 sec; F-stop: 0.0; FOV: 160 × 160 mm;
focal plane: 5. Subsequent X-rays were obtained and digi-
tized by the CCD camera. The following imaging parame-
ters were used for X-ray acquisition: exposure time: 60 sec;
F-stop: 3.7; FOV: 160 × 160 mm; focal plane: 5. OI scans
and x-rays were merged with the Kodak Molecular Imag-
ing Software 4.5 (Eastman Kodak Company, New Haven,
CT).
In our optical imaging studies we encountered several dif-
ficulties with autofluorescence. Depending on the applied
excitation and emission wavelength the skin and espe-
cially the hair of the animals were fluorescent and interfer-
ing with the signal of the deeper tissue e.g. the granulation
tissue. When imaging at a lower wavelength we had to
shave the animals in order to minimize the autofluores-
cence. However for this study we used a higher excitation
(755 nm) and emission wavelength of (830 nm), and
thus we could depict deeper tissue, such as granulation tis-
sue with a low autofluorescence effect.
Following the last imaging session, the rats were sacrificed
with an overdose of isoflurane and a bilateral thoracot-
omy. It is known that the signal intensity observed with
fluorescence reflectance imaging varies with the depth of
the target tissue. Therefore in order to study the biodistri-
bution of ICG and to compare the signal intensities of the
granulation tissue in vivo and ex vivo the lumbar spine
(L3–L5) and organs (liver, kidney, spleen, bowl, lung,
heart, bladder, urine and blood) were excised and imaged
ex vivo with the OI/X-ray system. Then the specimens
were processed for histopathology.
Image analysis
Image analysis was performed by two observers in consen-
sus. The optical images were evaluated qualitatively by
assessing the presence or absence of visibly increased flu-
orescence in the region of surgery compared to normal
contralateral muscle. An increased fluorescence of the left
paravertebral soft tissues was interpreted as presence of
postoperative granulation tissue. Quantitative analysis of
OI scans was performed with the Kodak Molecular Imag-
ing software 4.5. For each rat, the fluorescence signal
intensity (SI) of the paravertebral granulation tissue and
contralateral normal muscle was determined by operator
Overview of the different animal groups: the control group  (A) and the experimental group (B), further divided into two  dose groups, that received intravenous injections of 1 mg/kg  (A1, B1) and 10 mg/kg (A2, B2) ICG Figure 1
Overview of the different animal groups: the control 
group (A) and the experimental group (B), further 
divided into two dose groups, that received intrave-
nous injections of 1 mg/kg (A1, B1) and 10 mg/kg 
(A2, B2) ICG.Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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defined regions of interest (ROI). This ROI was saved by
the analysis software and applied to all other OI images of
the same animal. For OI scans from different days, the
same ROI was used, but manually repositioned by the
operator in order to match the anatomical area of surgery.
ΔSI was calculated by subtraction of SI of the postopera-
tive granulation tissue from the SI of the normal muscle:
ΔSI = SI granulation tissue - SI normal muscle. The relative fluores-
cence signal enhancement SI (%) of the left paravertebral
granulation tissue was quantified as: ΔSI (%) = {(SIpost -
SIpre)/SIpre} × 100%.
Histopathology
Lumbar spines and paravertebral soft tissues were har-
vested, placed in 10% non-buffered formalin and decalci-
fied using Formical-4 (Decal Chemical Corp, Tallman,
NY) for 2 days. Transverse sections were prepared through
the levels of the previous surgery, including the spine and
paravertebral tissues. The tissue was embedded in paraf-
fin, sectioned in 5 μm thick slices, stained with H&E and
Masson's Trichrome and evaluated using a Zeiss Axioskop
2 plus (Zeiss, Göttingen, Germany) at 1× and 40× magni-
fications. The presence, location and extent (diameter in
cm) of the granulation tissue was determined for each ani-
mal and analyzed by a pathologist at our institution.
Statistical analysis
All fluorescence data was presented as means and stand-
ard deviations of the means. Non-parametric Wilcoxon
tests were utilized because it was not possible to deter-
mine whether the data were Gaussian distributed. A
paired Wilcoxon test was used whenever there were
repeated observations on the same animal. A standard
Wilcoxon test was performed when comparing two differ-
ent animal populations. Results were considered statisti-
cally significant if p < 0.05. All statistical computations




Pre-contrast versus post-contrast scans
In all rats of the experimental group B, OI images showed
a marked signal enhancement of paravertebral soft tissue
at the area of surgery after intravenous injection of both
administered ICG doses, 1 mg/kg and 10 mg/kg ICG (Fig-
ure 2, 3). Corresponding quantitative ΔSI data of the left
paravertebral soft tissue were significantly higher on post-
contrast images (B1: 1075 ± 207; B2: 4310 ± 695) com-
pared to pre-contrast images (B1: 188 ± 60; B2: 216 ± 108)
(p < 0.05). In rats of the control group A, OI images
showed only a minimal and diffuse signal enhancement
of paravertebral soft tissue after intravenous injection of
both administered ICG doses. ΔSI data between pre- (A1:
161 ± 6; A2: 230 ± 16) and post-contrast (A1: 342 ± 56;
A2: 1311 ± 63) images were significantly different (p <
0.05, Figure 3).
Dynamic optical images of the experimental animal group B, pre and at 1–20 min after injection of different doses of ICG: 1 mg/ kg (B1) and 10 mg/kg (B2) Figure 2
Dynamic optical images of the experimental animal group B, pre and at 1–20 min after injection of different 
doses of ICG: 1 mg/kg (B1) and 10 mg/kg (B2).Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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Comparisons between animals injected with different ICG doses
In animals of group B, the contrast agent kinetics of the
left paravertebral soft tissues were different after injection
of the two different ICG doses. Following injections of the
low ICG dose (1 mg/kg), the area of surgery showed an
early peak enhancement (7 days p.s.: 1723.9 units; 14
days p.s.: 1957.4 units) at 1 min after ICG bolus injection,
followed by a rapid decline in fluorescence signal (Figure
2, 3). Following injections of the high ICG dose (10 mg/
kg), the area of surgery showed a slowly progressing con-
trast agent accumulation with a delayed peak enhance-
ment (7 days p.s. at 10 min p.i.: 5002.8 units; 14 days p.s.
at 15 min p.i.: 5546.6 units), which was followed by a pla-
teau phase (Figure 2, 3). Corresponding maximal quanti-
tative ΔSI(%) data were significantly higher using 10 mg/
kg (5547 ± 758) compared to 1 mg/kg ICG (1957 ± 623)
(p < 0.05). In addition, the time interval of significant
enhancement of granulation tissue was significantly
longer after injection of 10 mg/kg compared to 1 mg/kg
ICG (p < 0.05) (Figure 3).
Comparisons between group A and B
The fluorescence signal of the left paravertebral soft tissue
in the area of surgery on post-contrast images was mark-
edly higher in the animals in group B compared to ani-
mals in the control group A. Corresponding ΔSI% data of
the left paravertebral area were significantly higher for ani-
mals from group B (B1: 1075 ± 207; B2: 4310 ± 695) com-
pared to control animals in group A (A1: 342 ± 56; A2:
1311 ± 63) (p < 0.05).
Fusion
OI scans without X-rays did not allow an association of
the area of fluorescence with the level of the lumbar spine.
The Fusion of OI data with X-rays allowed an accurate
anatomical localization of the enhancing granulation tis-
sue (Figure 4). The enhancing left paravertebral soft tissue
could be associated with adjacent lumbar vertebrae. This
location corresponded to the area of surgery and the area
of granulation tissue seen on histopathology.
Ex vivo studies
Ex vivo OI scans of specimens (Figure 5) from rats of the
experimental group B showed a higher enhancement of
the spine at the location of surgery (11960 ± 695) com-
pared to the enhancement of the corresponding area in
the non-operated control group A (6398 ± 161) (p <
0.05). The enhancement of specimens of liver, kidneys,
Mean fluorescence signal intensities subtracted from the background signal intensity (a, b) and corresponding quantitative data  (c, d) of mean fluorescence signal intensities, standard deviation (SD) and the relative fluorescence signal enhancement (ΔSI%)  of the paravertebral soft tissue in the area of previous surgery of the experimental group compared to the controls as meas- ured before and continuously 1–25 min after injection of 1 mg/kg (a, c) and 10 mg/kg (b, d) ICG Figure 3
Mean fluorescence signal intensities subtracted from the background signal intensity (a, b) and corresponding quantitative data 
(c, d) of mean fluorescence signal intensities, standard deviation (SD) and the relative fluorescence signal enhancement (ΔSI%) 
of the paravertebral soft tissue in the area of previous surgery of the experimental group compared to the controls as meas-
ured before and continuously 1–25 min after injection of 1 mg/kg (a, c) and 10 mg/kg (b, d) ICG.Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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heart, lung, spleen, bowel, blood and urine were not sig-
nificantly different in both animal groups (p > 0.05).
Histology
Corresponding H&E and Mason's trichrome stains of the
spine confirmed the presence of granulation tissue at the
location of surgery (left paravertebral soft tissue adjacent
to L2/3) in the experimental group B (Figure 6), while the
control group A did not show any granulation tissue. The
measurements of the granulation tissue resulted in a
mean diameter of 3.1 mm (n = 12, standard deviation =
1.08).
Discussion
This study showed that the investigated OI/X-ray system
in conjunction with ICG-injection is a suitable technique
to depict granulation tissue after spine surgery. Unique to
this imaging system is its ability to acquire and fuse OI
and X-ray images and thereby, facilitate an anatomical ori-
entation with respect to the associated level of the lumbar
spine. In addition, this investigation revealed certain
advantages of using a high dose of 10 mg/kg of ICG, as
opposed to a lower dose of 1 mg/kg. The dose of 10 mg/
kg of ICG provided a stronger and prolonged enhance-
ment of the granulation tissue thus allowing for longer
observation times and improved detection of disease. Of
note, the FDA approved ICG dose for clinical applications
is 1 mg/kg. Although our data shows that this dose is suf-
ficient to depict granulation tissue, future studies should
evaluate if higher doses are also advantageous in the clin-
ical setting.
Representative optical and X-ray images with subsequent fusion of a rat at 7 days post surgery, 10 min after injection of 10 mg/ kg ICG, AP and lateral view Figure 4
Representative optical and X-ray images with subsequent fusion of a rat at 7 days post surgery, 10 min after 
injection of 10 mg/kg ICG, AP and lateral view. In order to visualize the areas with the highest fluorescence after injec-
tion of the contrast agent fusion was performed by fusing all signal intensities above 6000 units on the OI image. Thus, the 
areas of highest fluorescence are visible on the fused image.Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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The sensitivity of the OI/X-ray approach provides advan-
tages over the current standard, MR imaging. T2-weighted
MR images and gadolinium-DTPA-enhanced T1-weighted
MR images reveal detailed information about the exact
location and vascularization of granulation tissue as well
as related displacement and thickening of nerve roots
[30], but MR scans have a limited sensitivity. Peng et al.
argued that standard clinical MR scans with 3–4 mm thick
slices may not be able to detect small and poorly vascular-
ized areas of granulation tissue [31]. Our study demon-
strates that granulation tissue with an extent of 2–3 mm
can be clearly depicted with OI. Furthermore, OI is easier
to apply, faster (acquisition time is in the order of sec-
onds) and is markedly less expensive compared to MR. In
addition, new handheld OI scanners may allow investiga-
tors to perform studies at the bedside. Therefore, the high
sensitivity of our OI technique provides an essential
advantage for the detection of postoperative granulation
tissue.
To the best of our knowledge, OI has not been used to
image postoperative granulation tissue. However, other
fluorescent dyes have been successfully employed for the
detection of other chronic inflammations, such as arthritis
[32,33]. ICG is superior to other fluorescent contrast
agents for several reasons. ICG is FDA-approved for use in
patients. It has been used to measure tissue blood vol-
umes, cardiac output and hepatic function [34]. In addi-
tion, ICG has been applied for the detection of tumors
[35-37], for angiography in ophthalmology [38] and for
imaging of experimental arthritis [39]. ICG provides an
excellent penetration depth of light in tissue because it
displays strong absorption (~805 nm) and an intense
emission spectra (~830 nm), which occur at wavelengths
for which blood and other tissues are relatively transpar-
ent [40]. Finally, because of ICG's high affinity for blood
proteins, it displays enhancement kinetics of a blood pool
agent [41].
When applied in low concentrations, the majority of the
agent stays in the intravascular compartment and, thus,
leads to an early and short enhancement of the target tis-
sue. Conversely, when applied in high concentrations, the
biliary elimination of the agent is saturated, resulting in a
prolonged circulation time and leaking across the hyper-
permeable endothelium of the microvessels in the granu-
lation tissue with every perfusion. This results in a slow
accumulation of the agent in the interstitium of the gran-
ulation tissue, reflected by a slowly increasing and pro-
longed enhancement on OI. This prolonged
enhancement of granulation tissue with the high ICG
dose may be advantageous for potential future applica-
tions of handheld OI scanners, which are currently under
development.
Our data showed that the integrated OI/X-ray system is
particularly valuable for musculoskeletal and orthopedic
applications. Potential drawbacks of the fusion technique
could be misregistrations of the imaging data due to
movement. Since our animals were anesthetized, we did
not encounter any problems of this nature. However,
potential clinical applications would have to provide an
additional setup (e.g. holding devices) to avoid patient
movement and consecutive misregistrations of imaging
data. One limitation of our study is that we were not able
to separate perivertebral and perineural granulation tissue
because of the small anatomy of the rodent spine. Future
clinical applications have to show, if the larger anatomy in
patients will allow a separation of these two locations of
granulation tissue.
With the number of clinical spine surgeries increasing
every year, the management and treatment of postopera-
tive granulation tissue is an increasing problem [2,4].
Treating this granulation tissue is of crucial importance in
order to prevent complications in postoperative patients
[42]. New anti-inflammatory therapeutics are currently
being developed that aim to decrease the development
and growth of granulation tissue and, thereby, decrease
associated postoperative complications. The new OI-/X-
ray technique, described in this study, will be applied as a
non-invasive and cost-effective tool to directly and non-
invasively monitor the efficacy of new anti-inflammatory
drugs for the suppression of postoperative granulation tis-
sue. In addition, the described OI technique is in principle
ready to be applied in patients and could be used at the
bedside once handheld OI scanners become available.
Mean signal intensities of excised organs of the experimental  group B2 compared to the controls A2, measured ex vivo  after previous injection of 10 mg/kg ICG (a) Figure 5
Mean signal intensities of excised organs of the 
experimental group B2 compared to the controls A2, 
measured ex vivo after previous injection of 10 mg/kg 
ICG (a). Representative optical images of excised 
organs of a rat of the experimental animal group (b).Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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Representative Mason's trichrome stains of the lumbar spine (L2/3) of the experimental animal group B show the development  of granulation tissue at the left paravertebral soft tissue (a) Figure 6
Representative Mason's trichrome stains of the lumbar spine (L2/3) of the experimental animal group B show 
the development of granulation tissue at the left paravertebral soft tissue (a). The magnification of the granulation 
tissue reveals numerous macrophages (arrows in b), being characteristic for the formation of granulation tissue.Journal of Translational Medicine 2008, 6:73 http://www.translational-medicine.com/content/6/1/73
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